Please wait









Nordson Corporation Reports Record Third Quarter Fiscal 2026 Results and Increases Full Year Guidance

Third Quarter Highlights:
•Sales were an all-time quarterly record of $818 million, an increase of 10% year-over-year
•Earnings per diluted share were a record $2.73, up 23% year-over-year
•Adjusted earnings per diluted share were $3.25, also a quarterly record and up 19% year-over-year
•Continued strength in demand with backlog up 35% compared to prior year
•Increasing full year guidance for sales and earnings

WESTLAKE, Ohio--(BUSINESS WIRE)--August 19, 2026--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal third quarter ended July 31, 2026. Sales were a quarterly record of $818 million, an increase of 10% compared to the prior year’s third quarter sales of $742 million. The third quarter 2026 sales included an organic sales increase of approximately 12% driven by growth in all segments. Organic sales growth was partially offset by the net unfavorable impact of a prior year divestiture and an acquisition in the second quarter.
Net income was $153 million, or a record $2.73 of earnings per diluted share, compared to prior year’s third quarter net income of $126 million, or $2.22 of earnings per diluted share. Third quarter 2026 earnings included a non-cash loss on a minority investment recognized during the quarter. Excluding this item and acquisition-related amortization and costs, third quarter adjusted earnings per diluted share were a record $3.25, a 19% increase from the prior year adjusted earnings per diluted share of $2.73.
Third quarter EBITDA reached an all-time quarterly record of $262 million, or 32% of sales, an increase of 10% compared to prior year EBITDA of $239 million, also at 32% of sales.

Commenting on the Company’s fiscal 2026 third quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “The strong momentum of the first half continued through the third quarter, delivering results above the high-end of our most recent earnings guidance. The team’s strong execution of the Ascend Strategy, combined with our diversified portfolio, differentiated precision technology and operational excellence, positioned us to deliver record sales in all three segments while maintaining our best-in-class margin performance. In addition, strong free cash flow generation enabled us to further strengthen our balance sheet, return capital to shareholders, and continue investing in the business to support future growth. I want to thank our global employees for delivering on the needs of our customers and achieving another outstanding quarter.”

Third Quarter Segment Results
Record third quarter Industrial Precision Solutions sales of $367 million increased 5% from the prior year, inclusive of an organic sales increase of 3%, favorable currency translation of 1%, and an acquisition contribution of 1%. The organic sales increase was driven by strength in packaging, industrial coatings, polymer processing and nonwovens product lines. EBITDA in the quarter was $130 million, or 35% of sales, in line with prior year third quarter EBITDA of $130 million.
Medical and Fluid Solutions sales of $231 million, an all-time quarterly record, increased 5% compared to the prior year third quarter. Excluding the divestiture of the contract manufacturing business, organic sales increased 11%. The organic sales increase was driven by growth in engineered fluid solutions and medical product lines related to end market demand. EBITDA in the quarter was also a segment record $88 million, or 38% of sales, up 6% from the prior year third quarter EBITDA of $83 million.
Record quarterly Advanced Technology Solutions sales of $220 million increased 28% compared to the prior year third quarter, inclusive of an organic sales increase of 31% and unfavorable currency translation of 3%. The organic sales increase was driven by strong growth in electronics dispense and test and inspection product lines. EBITDA in the quarter was a segment record $66 million, or 30% of sales, up 58% from the prior year third quarter EBITDA of $42 million.
1








Outlook

The Company enters the fourth quarter with strong demand momentum and increased backlog, up 35% over the prior year.

Based on the continuing momentum of our end markets as evidenced by our backlog and order entry, the Company is increasing its full year guidance. Sales are now expected to be in the range of $3,035 to $3,075 million and adjusted earnings to be in the range of $11.80 to $12.00 per diluted share.

Reflecting on the full year outlook, Mr. Nagarajan said, “Based on backlog and order entry momentum, we expect the strong sales of the first nine months to continue through the fourth quarter. This puts us on track to achieve over $3 billion in annual revenue for the full year. We are delivering above-market organic growth through accelerating demand in key end markets. Our differentiated technology, close to the customer business model and the execution of the NBS Next growth framework have positioned us well to compound profitable growth this year and into the future.”
Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, August 20, 2026, at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Matt Matejka, senior director, investor relations at (440) 597-8495 or matthew.matejka@nordson.com.
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the U.S. or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serve global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com or www.linkedin.com/company/nordson-corporation.

2








NORDSON CORPORATION
SEGMENT INFORMATION (Unaudited)
(Dollars in thousands)
Three Months EndedNine Months Ended
July 31, 2026July 31, 2025July 31, 2026July 31, 2025
SALES
Industrial Precision Solutions$367,249 $350,784 $1,044,576 $970,079 
Medical and Fluid Solutions230,538 219,465 636,571 615,883 
Advanced Technology Solutions219,880 171,260 546,828 453,905 
Total sales$817,667 $741,509 $2,227,975 $2,039,867 
EBITDA
Industrial Precision Solutions$129,900 35%$130,130 37%$363,789 35%$356,453 37%
Medical and Fluid Solutions88,291 38%83,153 38%237,690 37%224,023 36%
Advanced Technology Solutions65,695 30%41,546 24%146,622 27%103,833 23%
Corporate expenses(21,403)(16,318)(47,441)(40,542)
Total EBITDA (non-GAAP) (1)
$262,483 32%$238,511 32%$700,660 31%$643,767 32%
(1) Total company EBITDA is a non-GAAP measure. Refer to the reconciliation of non-GAAP measures – net income to EBITDA.

3








NORDSON CORPORATION
CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(Dollars in thousands except for per-share amounts)
Three Months EndedNine Months Ended
July 31, 2026July 31, 2025July 31, 2026July 31, 2025
Sales$817,667 $741,509 $2,227,975 $2,039,867 
Cost of sales363,935 334,992 1,004,044 923,550 
Gross profit453,732 406,517 1,223,931 1,116,317 
Gross margin %55.5 %54.8 %54.9 %54.7 %
Selling and administrative expenses230,640 206,539 637,231 606,642 
Divestiture and related charges— 12,211 — 12,211 
Operating profit223,092 187,767 586,700 497,464 
Interest expense - net (20,359)(25,698)(64,680)(77,335)
Pension settlement charge— — (24,049)— 
Other expense - net(16,794)(2,945)(6,357)(5,380)
Income before income taxes185,939 159,124 491,614 414,749 
Income taxes33,093 33,340 88,070 81,909 
Net income$152,846 $125,784 $403,544 $332,840 
Weighted-average common shares outstanding:
Basic55,714 56,438 55,766 56,784 
Diluted56,027 56,728 56,084 57,084 
Earnings per share:
Basic earnings$2.74 $2.23 $7.24 $5.86 
Diluted earnings$2.73 $2.22 $7.20 $5.83 

4








NORDSON CORPORATION
CONSOLIDATED BALANCE SHEETS (Unaudited)
(Dollars in thousands)
July 31, 2026October 31, 2025
Cash and cash equivalents$113,431 $108,442 
Receivables - net648,827 587,843 
Inventories - net469,310 444,814 
Other current assets96,300 101,752 
Total current assets1,327,868 1,242,851 
Property, plant and equipment - net517,012 516,914 
Goodwill3,315,820 3,304,685 
Other assets787,220 853,231 
$5,947,920 $5,917,681 
Short term debt and current maturities of long-term debt$202,000 $315,000 
Accounts payable and accrued liabilities526,472 443,260 
Total current liabilities728,472 758,260 
Long-term debt1,529,005 1,681,254 
Other liabilities421,384 434,596 
Total shareholders' equity3,269,059 3,043,571 
$5,947,920 $5,917,681 

5








NORDSON CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)
(Dollars in thousands)
Nine Months Ended
July 31, 2026July 31, 2025
Cash flows from operating activities:
Net income$403,544 $332,840 
Depreciation and amortization109,446 112,454 
Divestiture and related charges— 12,211 
Pension settlement charge24,049 — 
Other non-cash items14,785 12,154 
Changes in operating assets and liabilities and other18,649 46,605 
Net cash provided by operating activities    570,473 516,264 
Cash flows from investing activities:
Additions to property, plant and equipment(40,313)(49,002)
Acquisition of business, net of cash acquired(11,643)— 
Other - net(3,513)4,272 
Net cash used in investing activities(55,469)(44,730)
Cash flows from financing activities:
Repayment of debt - net(258,025)(94,664)
Repayment of finance lease obligations(5,633)(4,083)
Dividends paid(137,384)(133,008)
Issuance of common shares49,143 5,419 
Purchase of treasury shares(158,792)(218,194)
Net cash used in financing activities(510,691)(444,530)
Effect of exchange rate change on cash:676 4,832 
Net change in cash and cash equivalents4,989 31,836 
Cash and cash equivalents:
Beginning of period108,442 115,952 
End of period$113,431 $147,788 

6








NORDSON CORPORATION
SALES BY GEOGRAPHIC SEGMENT (Unaudited)
(Dollars in thousands)
Three Months EndedSales Variance
July 31, 2026July 31, 2025OrganicAcquisitions / DivestituresCurrencyTotal
SALES BY SEGMENT
Industrial Precision Solutions$367,249 $350,784 3.3 %0.9 %0.5 %4.7 %
Medical and Fluid Solutions230,538 219,465 10.6 %(5.6)%— %5.0 %
Advanced Technology Solutions219,880 171,260 30.9 %— %(2.5)%28.4 %
Total sales$817,667 $741,509 11.7 %(1.2)%(0.2)%10.3 %
SALES BY GEOGRAPHIC REGION
Americas$331,471 $314,568 7.3 %(2.5)%0.6 %5.4 %
Europe192,432 186,620 3.2 %(0.3)%0.2 %3.1 %
Asia Pacific293,764 240,321 24.1 %(0.1)%(1.8)%22.2 %
Total sales$817,667 $741,509 11.7 %(1.2)%(0.2)%10.3 %
Nine Months EndedSales Variance
July 31, 2026July 31, 2025OrganicAcquisitions / DivestituresCurrencyTotal
SALES BY SEGMENT
Industrial Precision Solutions$1,044,576 $970,079 3.8 %0.6 %3.3 %7.7 %
Medical and Fluid Solutions636,571 615,883 7.1 %(4.6)%0.9 %3.4 %
Advanced Technology Solutions546,828 453,905 20.1 %— %0.4 %20.5 %
Total sales$2,227,975 $2,039,867 8.4 %(1.2)%2.0 %9.2 %
SALES BY GEOGRAPHIC REGION
Americas$901,654 $874,868 4.5 %(2.3)%0.9 %3.1 %
Europe569,351 526,878 3.1 %(0.2)%5.2 %8.1 %
Asia Pacific756,970 638,121 18.2 %(0.1)%0.5 %18.6 %
Total sales$2,227,975 $2,039,867 8.4 %(1.2)%2.0 %9.2 %
7








NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedNine Months Ended
July 31, 2026July 31, 2025July 31, 2026July 31, 2025
Net income$152,846 $125,784 $403,544 $332,840 
Income taxes33,093 33,340 88,070 81,909 
Interest expense - net20,359 25,698 64,680 77,335 
Pension settlement charge— — 24,049 — 
Other expense - net16,794 2,945 6,357 5,380 
Inventory step-up amortization (1)
2,269 — 3,404 3,135 
Severance and other (1)
— 451 — 16,725 
Acquisition-related costs (1)
576 235 1,110 1,778 
Divestiture and related charges— 12,211 — 12,211 
Adjusted operating profit225,937 200,664 591,214 531,313 
Depreciation and amortization36,546 37,847 109,446 112,454 
EBITDA (non-GAAP) (2)
$262,483 $238,511 $700,660 $643,767 
(1) Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions.
(2) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as non-recurring cost reduction actions, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.


8








NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited)
(Dollars in thousands)
Three Months EndedNine Months Ended
July 31, 2026July 31, 2025July 31, 2026July 31, 2025
GAAP AS REPORTED
Net income$152,846 $125,784 $403,544 $332,840 
Diluted earnings per share$2.73 $2.22 $7.20 $5.83 
Shares outstanding - diluted56,027 56,728 56,084 57,084 
ADJUSTMENTS
Inventory step-up amortization (1)
$2,269 $— $3,404 $3,135 
Acquisition costs (1)
576 235 1,110 1,778 
Severance and other (1)
— 451 — 16,725 
Acquisition amortization of intangibles19,345 20,092 58,320 59,099 
Entity liquidation— — — 988 
Non-cash loss on minority investments (2)
14,892 — 2,481 — 
Pension settlement charge— — 24,049 — 
Total adjustments$37,082 $32,989 $89,364 $93,936 
Adjustments net of tax$29,364 $29,084 $72,075 $78,451 
EPS effect of adjustments$0.52 $0.51 $1.29 $1.37 
NON-GAAP
Adjusted net income (3)
$182,210 $154,868 $475,619 $411,291 
Adjusted earnings per share (4)
$3.25 $2.73 $8.48 $7.20 
(1) Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions.
(2) Represents non-cash loss on minority investments accounted for at fair value.
(3) Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.
(4) Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.
9








NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - OPERATING CASH FLOW TO FREE CASH FLOW (Unaudited)
(Dollars in thousands)

Year to Date
July 31, 2026April 30, 2026
Net cash provided by operating activities$570,473 $321,101 
Additions to property, plant and equipment(40,313)(27,693)
Free cash flow (1)
$530,160 $293,408 
Free cash flow - quarter to date (1)
$236,752 
Net income $403,544 $250,698 
Non-cash loss on minority investments and pension charge - after-tax20,552 9,383 
Net income excluding non-cash loss on minority investments and pension loss (2)
$424,096 $260,081 
Free cash flow conversion (3)
125 %113 %
Net income excluding non-cash loss on minority investments and pension charge - quarter to date (2)
$164,015 
Free cash flow conversion - quarter to date (3)
144 %
Year to Date
July 31, 2025April 30, 2025
Net cash provided by operating activities$516,264 $278,292 
Additions to property, plant and equipment(49,002)(37,439)
Free cash flow (1)
$467,262 $240,853 
Free cash flow - quarter to date (1)
$226,409 
Net income$332,840 $207,056 
Free cash flow conversion (3)
140 %116 %
Net income - quarter to date (2)
$125,784 
Free cash flow conversion - quarter to date (3)
180 %
(1) Free cash flow is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Net cash provided by operating activities minus Additions to property, plant and equipment.
(2) Net income excluding non-cash loss on minority investments and pension charge is a non-GAAP measure used by management as an input to the calculation of Free cash flow conversion and is defined as Net income excluding non-cash losses (gains) on minority investments and pension settlement charge.
(3) Free cash flow conversion is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Free cash flow divided by Net income excluding non-cash losses on minority investments and pension settlement charge.


10








Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS, EBITDA, free cash flow, and free cash flow conversion, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.



Contact
Matt Matejka
Senior Director
Investor Relations
(440) 597-8495
Matthew.Matejka@nordson.com
11